FUJISAKI SHIGEMI has a total of 12 patent applications. Its first patent ever was published in 1986. It filed its patents most often in Japan, Germany and United Kingdom. Its main competitors in its focus markets pharmaceuticals and biotechnology are ALDAGEN INC, DIAMYD THERAPEUTICS AB and AUROGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 7 | |
#2 | Germany | 2 | |
#3 | United Kingdom | 2 | |
#4 | France | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Fujisaki Shigemi | 12 |
#2 | Fujisaki Takashi | 6 |
#3 | Yoshida Junichi | 6 |
#4 | Fujisaki Yasuhiro | 5 |
#5 | Honda Mitsuo | 4 |
#6 | Nakamura Masahiko | 3 |
#7 | Tomioka Chikanori | 2 |
#8 | Kobayashi Haruhiko | 1 |
#9 | Inoue Yukio | 1 |
#10 | Kawazoe Kanehisa | 1 |
Publication | Filing date | Title |
---|---|---|
JP2002087990A | Prophylactic and therapeutic agent for viral illness for example, aids, hepatitis b, hepatitis c, influenza and the like | |
JPH11199510A | Preventive/therapeutic agent for aids virus and influenza virus | |
JPH11199509A | Preventive/therapeutic agent for hepatitis b and c | |
JPH0840930A | Agent for preventing and treating aids or viral disease such as chronic hepatitis, b type hepatitis or c type hetatitis | |
JPH0775570A | Novel metalloend peptidase f, its production and medicine containing the same as active component | |
DE3941324A1 | ACTIVATOR FOR INJURED NEUROCYTES FOR THE PREVENTION AND TREATMENT OF DISEASES | |
JPS62215533A | Preventive and remedy for intractable chronic disease |